Clinical Trials Logo

Clinical Trial Summary

The purpose of this research is to study the natural history of congenital disorders of glycosylation and its causes and treatments.


Clinical Trial Description

The investigators are conducting a natural history study of patients with congenital disorders of glycosylation (CDG). The study will look into the progression of the disease amongst the participants and also look at the clinical symptoms and how they vary amongst different diseased population groups. The participants will be asked to fill out questionnaires either on their own or with a provider that will grade the severity of disease and document symptoms and diet. Participants will have an opportunity to submit blood, urine, and stool samples that will be tested for biomarkers for CDG. Participants will also complete dietary food records, physical exams, CDG scores, and the PROMIS questionnaires to assess disease progression and severity. ;


Study Design


Related Conditions & MeSH terms

  • Congenital Disorders of Glycosylation

NCT number NCT04199000
Study type Observational
Source Icahn School of Medicine at Mount Sinai
Contact Eva Morava-Kozicz, PhD, MD
Phone (504) 444-9386
Email eva.morava@mssm.edu
Status Recruiting
Phase
Start date October 8, 2019
Completion date October 2024

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04201067 - Large-Scale Metabolomic Profiling for the Diagnosis of Inborn Errors of Metabolism
Completed NCT03250728 - Role of the Endothelium in Stroke-like Episode Among CDG Patients N/A
Recruiting NCT02089789 - Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
Completed NCT02955264 - Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation N/A
Completed NCT03560570 - Study of Hemostasis in Patients With Congenital Disorder of Glycosylation